Obstetrics & Gynecology Doctors in North Easton, MA Accepting Medicare

6 Obstetrics & Gynecology doctors found. Showing 1 - 6

Tutasi K Waters, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2 Washington St Ste 210, North Easton, MA 02356 Phone: 508-894-8750    Fax: 508-894-8752

Ms. Lisa Domal Sweeney, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 15 Roche Bros Way Ste 220, One Washington St, North Easton, MA 02356 Phone: 508-230-0155    Fax: 508-230-0145

Mohammed Al Qaraghouli, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 31 Roche Bros Way, North Easton, MA 02356 Phone: 508-894-8760

Keith S Merlin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 31 Roche Bros Way, North Easton, MA 02356 Phone: 508-894-8740    Fax: 508-894-8742

Lauren R Brown, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 31 Roche Brothers Way, Two Washington Place, Suite 210, North Easton, MA 02356 Phone: 508-894-8740    Fax: 508-894-8742

Dr. Yiran Xu, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 31 Roche Bros Way, North Easton, MA 02356 Phone: 508-894-8740    Fax: 508-894-8742

News Archive

Conceptus reports clinical success of its Essure non-incisional permanent birth control procedure

Conceptus, Inc., developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that the clinical success of the Essure® procedure will be highlighted at the 18th Annual Congress of the European Society for Gynaecological Endoscopy (ESGE) in Florence, Italy from October 28-31, 2009.

New Canadian drug submission for cannabis-based medicine

GW Pharmaceuticals and Bayer HealthCare, Pharmaceuticals Division - Canada have announced that GW has submitted a New Drug Submission for Sativex®, a cannabis-based medicinal extract product, to Health Canada.

Pharmacyclics announces financial results for fourth quarter and FY 2009

Pharmacyclics, Inc. today reported financial results for its fourth quarter and fiscal year ended June 30, 2009. During the fourth quarter of fiscal 2009 Pharmacyclics incurred a GAAP net loss of $5.4 million, or $0.20 per share, compared to a net loss of $4.6 million, or $0.18 per share for the fourth quarter of fiscal 2008.

TTP receives IOP Innovation Award for SonicSense technology

TTP has been awarded a prestigious Innovation Award by the Institute of Physics for its SonicSense technology, which turns inexpensive piezoelectric buzzers used in doorbells or smoke alarms into highly-accurate, stable and low-power gas sensors.

Much remains to be done for autism spectrum disorders, say experts

Scientific understanding and medical treatments for autism spectrum disorders (ASDs) have advanced significantly over the past several years, but much remains to be done, say experts from the Center for Autism Research at The Children's Hospital of Philadelphia who published a scientific review of the field today.

Read more Medical News

› Verified 3 days ago